Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities
Utilization of telehealth as part of the cancer care delivery continuum dramatically escalated in response to the COVID-19 pandemic at major cancer centers across the globe. The rapid shift toward telehealth visits for nontreatment cancer care provided immediate benefit through reducing unnecessary risk of exposure, overcoming transportation barriers faced by both patients and caregivers, and fast-tracking care transformation. As such, delineating the impact of telehealth on access, health equity, quality, and outcomes will be essential for refining the use of digital strategies and telehealth toward optimizing cancer care. Herein, experiences to date with telehealth usage for oncology care are reviewed, and priorities are outlined for postpandemic opportunities to improve the lives of patients with cancer through telemedicine.
Top-30
Journals
|
1
2
3
4
5
|
|
|
JCO Oncology Practice
5 publications, 7.46%
|
|
|
JAMA network open
3 publications, 4.48%
|
|
|
Journal of Medical Internet Research
3 publications, 4.48%
|
|
|
JCO clinical cancer informatics
3 publications, 4.48%
|
|
|
International Journal of Environmental Research and Public Health
2 publications, 2.99%
|
|
|
Supportive Care in Cancer
2 publications, 2.99%
|
|
|
Current Oncology
2 publications, 2.99%
|
|
|
Journal of Telemedicine and Telecare
2 publications, 2.99%
|
|
|
Cancers
2 publications, 2.99%
|
|
|
Gynecologic Oncology
2 publications, 2.99%
|
|
|
Oncologist
2 publications, 2.99%
|
|
|
Journal of the National Cancer Institute. Monographs
2 publications, 2.99%
|
|
|
JMIR Cancer
2 publications, 2.99%
|
|
|
Journal of Surgical Oncology
1 publication, 1.49%
|
|
|
BMC Health Services Research
1 publication, 1.49%
|
|
|
Journal of Cancer Survivorship
1 publication, 1.49%
|
|
|
The Lancet Haematology
1 publication, 1.49%
|
|
|
Asia-Pacific Journal of Oncology Nursing
1 publication, 1.49%
|
|
|
IPEM-Translation
1 publication, 1.49%
|
|
|
Preventive Medicine
1 publication, 1.49%
|
|
|
European Journal of Surgical Oncology
1 publication, 1.49%
|
|
|
PLoS ONE
1 publication, 1.49%
|
|
|
European Journal of Cancer Care
1 publication, 1.49%
|
|
|
Journal of Rural Health
1 publication, 1.49%
|
|
|
Palliative and Supportive Care
1 publication, 1.49%
|
|
|
JAMA Oncology
1 publication, 1.49%
|
|
|
International Journal of Clinical Practice
1 publication, 1.49%
|
|
|
Patient
1 publication, 1.49%
|
|
|
International Journal of Nursing Studies
1 publication, 1.49%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
|
|
|
Elsevier
10 publications, 14.93%
|
|
|
MDPI
8 publications, 11.94%
|
|
|
American Society of Clinical Oncology (ASCO)
8 publications, 11.94%
|
|
|
JMIR Publications
7 publications, 10.45%
|
|
|
Springer Nature
7 publications, 10.45%
|
|
|
Wiley
6 publications, 8.96%
|
|
|
American Medical Association (AMA)
4 publications, 5.97%
|
|
|
Public Library of Science (PLoS)
2 publications, 2.99%
|
|
|
SAGE
2 publications, 2.99%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 2.99%
|
|
|
Society for Translational Oncology
2 publications, 2.99%
|
|
|
Oxford University Press
2 publications, 2.99%
|
|
|
Cambridge University Press
1 publication, 1.49%
|
|
|
Mary Ann Liebert
1 publication, 1.49%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.49%
|
|
|
Taylor & Francis
1 publication, 1.49%
|
|
|
Georg Thieme Verlag KG
1 publication, 1.49%
|
|
|
Frontiers Media S.A.
1 publication, 1.49%
|
|
|
Emerald
1 publication, 1.49%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.